Evidence map›Paper›PMID 25685322›Full record

ArticleF1000Research2014

ABS-Scan: In silico alanine scanning mutagenesis for binding site residues in protein-ligand complex.

Praveen Anand, Deepesh Nagarajan, Sumanta Mukherjee, Nagasuma Chandra

Abstract read
In one paragraph

Article in F1000Research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Insight into Protein Engineering: FromCurrent pharmaceutical design · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. SARS-CoV-2 3CLScience translational medicine · 2023
    Article
  7. Article
  8. VietnameseMolecules (Basel, Switzerland) · 2022
    Article
  9. Molecules (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Praveen AnandDepartment of Biochemistry, Indian Institute of Science, Bangalore, 560012, India.
Deepesh NagarajanDepartment of Biochemistry, Indian Institute of Science, Bangalore, 560012, India.
Sumanta MukherjeeIISc Mathematics Initiative, Indian Institute of Science, Bangalore, 560012, India.
Nagasuma ChandraDepartment of Biochemistry, Indian Institute of Science, Bangalore, 560012, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most physiological processes in living systems are fundamentally regulated by protein-ligand interactions. Understanding the process of ligand recognition by proteins is a vital activity in molecular biology and biochemistry. It is well known that the residues present at the binding site of the protein form pockets that provide a conducive environment for recognition of specific ligands. In many cases, the boundaries of these sites are not well defined. Here, we provide a web-server to systematically evaluate important residues in the binding site of the protein that contribute towards the ligand recognition through in silico alanine-scanning mutagenesis experiments. Each of the residues present at the binding site is computationally mutated to alanine. The ligand interaction energy is computed for each mutant and the corresponding ΔΔG values are calculated by comparing it to the wild type protein, thus evaluating individual residue contributions towards ligand interaction. The server will thus provide a ranked list of residues to the user in order to obtain loss-of-function mutations. This web-tool can be freely accessed through the following address: http://proline.biochem.iisc.ernet.in/abscan/.

Identifiers

PMID25685322
PMCPMC4319546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.